Economics
Indonesia Keeps Sinovac, Says Best Is Shot That’s Available
Photographer: Chaideer Mahyuddin/AFP/Getty Images
This article is for subscribers only.
Indonesia will keep using the vaccines developed by China’s Sinovac Biotech Ltd. and U.K.’s AstraZeneca Plc. to curb the spread of Covid-19 because they have met the standards set by the World Health Organization, according to the government.
WHO has endorsed the vaccines as safe and have sufficient efficacy rates, spokesperson for the Health Ministry Siti Nadia Tarmizi said by phone on Monday. “We can assure you that the vaccines are safe, beneficial and able to boost our immunity.”